Cosmetic upper-facial rejuvenation with botulinum

Journal of Otolaryngology

Volumn 26, Issue 2, 1997, Pages 92-96

  Ellis, David A F ^a,b   Tan, Andre K W ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b Toronto Ctr Facial Cosmetic Surg   (Canada)

Author keywords

botox; botulinum toxin; complication; forehead wrinkling; injection technique; upper facial wrinkling

Indexed keywords

BOTULINUM TOXIN A;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; FACE DEFORMITY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; PRIORITY JOURNAL; REJUVENATION; SKINFOLD;

BOTULINUM TOXIN TYPE A; DRUG MONITORING; FACIAL EXPRESSION; HUMANS; NEUROMUSCULAR AGENTS; PROSPECTIVE STUDIES; RHYTIDOPLASTY; SKIN AGING; TREATMENT OUTCOME;

EID: 0031011249     PISSN: 03816605     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Toledo G, Tate J. Coronal approach for rejuvenation of the eyes and forehead. Arch Otolaryngol Head Neck Surg 1986; 112:738-744.
2. Ellis DAF, Masri H. The effect of facial animation on the aging upper half of the face. Arch Otolaryngol Head Neck Surg 1989; 115:710-713.
3. Blitzer A, Brin MF, Keen MS, et al. Botulinum toxin for the treatment of hyperfunctional lines of the face. Arch Otolaryngol Head Neck Surg 1993; 119:1018-1022.
4. Simpson LL. The origin, structure, and pharmacological activity of botulinum toxin. Pharmacol Rev 1981; 33: 155-188.
5. Simpson LL. Peripheral actions of the botulinum toxins. In: Simpson LL, ed. Botulinum neurotoxin and tetanus toxin. Orlando, FL: Academic Press, 1989:153-178.
6. Sellin LC. The action of botulinum toxin at the neuromuscular junction. Med Biol 1981; 59:11-20.
7. Poulain B, Mochida S, Weller U, et al. Heterologous combinations of heavy and light chains from botulinum neurotoxin A and tetanus toxin inhibit neurotransmitter release in aplasia. J Biol Chem 1991; 266:9580-9585.
8. Buzzell RA. Effects of solar radiation on the skin. Otolaryngol Clin North Am 1993; 26:1-119.
9. National Institutes of Health Consensus Development Conference. Clinical use of botulinum toxin. Bethesda, MD: National Institutes of Health, 1990; 8:1-20.